Cynergistek, Inc. (CTEK) EPS Estimated At $0.08

March 14, 2018 - By Adrian Mccoy

 Cynergistek, Inc. (CTEK) EPS Estimated At $0.08

Analysts expect Cynergistek, Inc. (NYSEAMERICAN:CTEK) to report $0.08 EPS on March, 26.They anticipate $0.09 EPS change or 52.94 % from last quarter’s $0.17 EPS. CTEK’s profit would be $760,146 giving it 15.41 P/E if the $0.08 EPS is correct. After having $0.24 EPS previously, Cynergistek, Inc.’s analysts see -66.67 % EPS growth. The stock decreased 1.40% or $0.07 during the last trading session, reaching $4.93. About 26,159 shares traded. Cynergistek, Inc. (NYSEAMERICAN:CTEK) has 0.00% since March 14, 2017 and is . It has underperformed by 16.70% the S&P500.

Cynergistek, Inc. provides outsourced document management services and IT security consulting services primarily to the healthcare industry in the United States. The company has market cap of $46.84 million. It offers workflow solutions; and creates manageable, dependable print management programs by managing the back-office processes of hospital clients. It has a 9.34 P/E ratio. The firm also provides technical risk and penetration testing, process and procedure development, and risk management services based on its proprietary Delphiis IT Risk Manager SaaS Solution.

More notable recent Cynergistek, Inc. (NYSEAMERICAN:CTEK) news were published by: which released: “Austinites fetch $34M buyout for health care consultancy” on January 17, 2017, also with their article: “Annual Alpha Select Craig-Hallum Capital Group Conference” published on November 06, 2017, published: “CynergisTek Reports Third Quarter 2017 Financial Results” on November 09, 2017. More interesting news about Cynergistek, Inc. (NYSEAMERICAN:CTEK) were released by: and their article: “CynergisTek Inc.” published on September 19, 2017 as well as‘s news article titled: “CynergisTek Makes Advance Payment of Bank Debt and Negotiates New Financing …” with publication date: March 12, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.